These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19903070)

  • 1. Role of CSF-1 in progression of epithelial ovarian cancer.
    Chambers SK
    Future Oncol; 2009 Nov; 5(9):1429-40. PubMed ID: 19903070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic cytokines as tumor markers in gynecological malignancies. A multivariate analysis in epithelial ovarian cancer patients.
    Lawicki S; Gacuta-Szumarska E; Będkowska GE; Szmitkowski M
    Growth Factors; 2012 Dec; 30(6):357-66. PubMed ID: 22988839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase.
    Chambers SK; Wang Y; Gertz RE; Kacinski BM
    Cancer Res; 1995 Apr; 55(7):1578-85. PubMed ID: 7882368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of serum biomarkers implicated in the onset and progression of serous ovarian cancer in a rat model using iTRAQ technique.
    Huang Y; Zhang X; Jiang W; Wang Y; Jin H; Liu X; Xu C
    Eur J Obstet Gynecol Reprod Biol; 2012 Nov; 165(1):96-103. PubMed ID: 22818854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve growth factor stimulates cellular proliferation of human epithelial ovarian cancer.
    Urzua U; Tapia V; Geraldo MP; Selman A; Vega M; Romero C
    Horm Metab Res; 2012 Sep; 44(9):656-61. PubMed ID: 22411587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal.
    van Haaften-Day C; Shen Y; Xu F; Yu Y; Berchuck A; Havrilesky LJ; de Bruijn HW; van der Zee AG; Bast RC; Hacker NF
    Cancer; 2001 Dec; 92(11):2837-44. PubMed ID: 11753957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Messenger RNA decay of macrophage colony-stimulating factor in human ovarian carcinomas in vitro.
    Chambers SK; Kacinski BM
    J Soc Gynecol Investig; 1994; 1(4):310-6. PubMed ID: 9419789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian enzymatically active stromal cells can be a promoter of ovarian surface epithelial tumor.
    Song Z
    Med Hypotheses; 2011 Sep; 77(3):356-8. PubMed ID: 21641729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropins and ovarian cancer.
    Choi JH; Wong AS; Huang HF; Leung PC
    Endocr Rev; 2007 Jun; 28(4):440-61. PubMed ID: 17463396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression.
    Deng J; Wang L; Chen H; Li L; Ma Y; Ni J; Li Y
    Cancer Metastasis Rev; 2013 Dec; 32(3-4):535-51. PubMed ID: 23609751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies.
    Baiocchi G; Kavanagh JJ; Talpaz M; Wharton JT; Gutterman JU; Kurzrock R
    Cancer; 1991 Feb; 67(4):990-6. PubMed ID: 1825026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
    Fan Q; Cai Q; Xu Y
    Oncotarget; 2015 Sep; 6(29):27688-99. PubMed ID: 26299613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma.
    Toy EP; Chambers JT; Kacinski BM; Flick MB; Chambers SK
    Gynecol Oncol; 2001 Feb; 80(2):194-200. PubMed ID: 11161859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism for the Decision of Ovarian Surface Epithelial Stem Cells to Undergo Neo-Oogenesis or Ovarian Tumorigenesis.
    Xu J; Zheng T; Hong W; Ye H; Hu C; Zheng Y
    Cell Physiol Biochem; 2018; 50(1):214-232. PubMed ID: 30336465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of c-fms proto-oncogene product by ovarian cancer cell lines with effects of macrophage colony-stimulating factor on proliferation.
    Suzuki M; Sekiguchi I; Ohwada M; Sato I; Matsui T; Tanabe T; Hashimoto S; Yamada M
    Oncology; 1996; 53(2):99-103. PubMed ID: 8604248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of macrophage colony-stimulating factor (CSF-1) and its receptor, c-fms, in normal ovarian granulosa cells leads to cell proliferation and tumorigenesis.
    Keshava N; Gubba S; Tekmal RR
    J Soc Gynecol Investig; 1999; 6(1):41-9. PubMed ID: 10065425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated CTHRC1 promotes human epithelial ovarian cancer invasion through activating EGFR signaling.
    Ye J; Chen W; Wu ZY; Zhang JH; Fei H; Zhang LW; Wang YH; Chen YP; Yang XM
    Oncol Rep; 2016 Dec; 36(6):3588-3596. PubMed ID: 27779718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 inhibition by celecoxib in epithelial ovarian cancer attenuates E-cadherin suppression through reduced Snail nuclear translocation.
    Wang YP; Wang QY; Li CH; Li XW
    Chem Biol Interact; 2018 Aug; 292():24-29. PubMed ID: 29932878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF-1 signal transduction.
    Hamilton JA
    J Leukoc Biol; 1997 Aug; 62(2):145-55. PubMed ID: 9261328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.